Machine Learning

A massive proptech rollout by Highmark Residential signals a new era for renters, replacing rigid schedules with on-demand, self-guided apartment tours.

As AI reshapes creative fields, Minted's Independent Artist Day celebrates a powerful counter-narrative: technology can empower, not erase, human creativity.

The strategic merger combines a massive clearinghouse with a P&C billing specialist, aiming to automate healthcare's complex back-office operations.

Dr. Amit Singal, a leading hepatologist, joins Curve Biosciences as CMO, aiming to leverage AI to find chronic liver disease before it becomes incurable.

Century Health and VCU are building a massive AI-driven database to decode steatotic liver disease, a silent epidemic affecting nearly 2 billion people.

With backing from General Catalyst, Numos is building a transparent AI platform to win over finance teams wary of 'black-box' solutions.

A massive data center network is planned for Asia, but a closer look at the partners reveals a complex picture of ambition, innovation, and high-stakes risk.

IFF targets the booming pet wellness market with PureStrong™, a probiotic built from canine science. Is this the future of dog digestive health?

Reprotech and TMRW Life Sciences combine, creating a tech-driven titan set to manage over 1M fertility specimens and reshape the future of IVF storage.

A new peer-reviewed study finds InsideTracker's AI platform drives sustained health improvements, setting a new bar for scientific proof in digital wellness.

A novel triple-action topical spray for male pattern baldness enters a pivotal clinical trial, potentially disrupting a multi-billion dollar market.

A new Australian-funded program will train women in cybersecurity in Fiji, Samoa, and Tonga, aiming to bolster regional defenses and promote gender equality.

A Utah fintech just landed a massive credit line to disrupt the luxury auto market. Here's how its AI platform is changing the game for car collectors.

Boston-based Reclaim Health wins a top AI award for its platform that automatically finds and recovers millions in medical billing errors for employers and staff.

With FDA clearance, Zeto New Wave™ promises to slash EEG wait times and ease staff shortages, making critical brain health data more accessible.

The classic internet speed test is obsolete. A new standard, TR-471, is shifting focus to what matters: latency, jitter, and reliability under load.

With FDA clearance for clinical trials, CanWell Pharma’s novel CAN016 ADC brings a two-pronged attack against drug-resistant HER2-positive cancers.

A new fintech partnership aims to provide personal loans to a vast, underserved market of Canadians with thin or non-existent credit histories.

AvenCell has dosed the first patient with AVC-203, a novel allogeneic CAR-T therapy, aiming to make advanced cancer treatment more accessible and effective.

Scientists propose a unifying model combining 'viral mimicry' and 'cancer dark matter,' potentially revolutionizing how our immune system recognizes and fights tumors.